Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence

被引：0
|
作者：
Kelly, C. [1 ]
Barnett, G. [2 ]
Iqbal, M. S. [3 ]
机构：
[1] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Hills Rd, Cambridge CB2 0QQ, England
[3] Newcastle Univ, Freeman Hosp, Newcastle Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 09期
关键词：
Chemotherapy; head and neck cancer; immunotherapy; pembrolizumab; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; CETUXIMAB; RECURRENT;
D O I：
10.1016/j.clon.2024.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：534 / 536
页数：3
相关论文
共 50 条
  • [1] Efficacy of pembrolizumab-chemotherapy vs. cetuximabchemotherapy in head and neck squamous cell carcinoma
    Jeanice, T.
    Gunawan, C. M. A.
    Liem, E. C.
    Gunawan, Y. R.
    Evangelista, I. D.
    Sukendro, G. M.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1402 - S1402
  • [2] PALLIATIVE CISPLATIN AND CAPECITABINE CHEMOTHERAPY IN HEAD AND NECK CANCER
    Califano, R.
    Jyoti, B.
    Hodgson, C.
    Mais, K.
    Lee, L. W.
    ANNALS OF ONCOLOGY, 2010, 21 : 327 - 327
  • [3] THE TIME SPENT AT HOME BY PATIENTS RECEIVING PALLIATIVE CHEMOTHERAPY FOR HEAD AND NECK-CANCER
    MORTON, RP
    STELL, PM
    WILSON, JA
    CLINICAL OTOLARYNGOLOGY, 1984, 9 (02): : 138 - 139
  • [4] Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
    Patil, V. M.
    Noronha, V
    Joshi, A.
    Nayak, L.
    Pande, N.
    Chandrashekharan, A.
    Dhumal, S.
    Bhattacharjee, A.
    Banavali, S.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 25 - +
  • [5] A CONTROLLED TRIAL OF PALLIATIVE CHEMOTHERAPY IN HEAD AND NECK-CANCER
    MORTON, RP
    STELL, PM
    WILSON, J
    CLINICAL OTOLARYNGOLOGY, 1984, 9 (04): : 249 - 249
  • [6] Combined chemotherapy and radiation therapy in head and neck cancer
    Nishiyama, K
    Takahashi, H
    Okamoto, M
    Yao, KZ
    Inagi, K
    Nakayama, M
    Makoshi, T
    ACTA OTO-LARYNGOLOGICA, 1996, : 79 - 82
  • [7] REGIONAL CHEMOTHERAPY WITH COMBINED DRUGS IN CANCER OF HEAD AND NECK
    DONEGAN, WL
    HARRIS, P
    CANCER, 1976, 38 (04) : 1479 - 1483
  • [8] Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
    McCusker, Michael G.
    Orkoulas-Razis, Dennis
    Mehra, Ranee
    ONCOTARGETS AND THERAPY, 2020, 13 : 3047 - 3059
  • [9] INTEGRATION OF CHEMOTHERAPY INTO A COMBINED MODALITY TREATMENT PLAN FOR HEAD AND NECK-CANCER - A REVIEW
    GLICK, JH
    TAYLOR, SG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (02): : 229 - 242
  • [10] Palliative chemotherapy of head and neck cancer: Present status and future development
    Hennemann, B
    LARYNGO-RHINO-OTOLOGIE, 2006, 85 (03) : 172 - 178
12345